Deverra Therapeutics
About:
Deverra Therapeutics is a biotechnology company that develops allogeneic cellular immunotherapies.
Website: https://www.deverratx.com/
Top Investors: Andy Hill Cancer Research Endowment (CARE) Fund
Description:
Deverra Therapeutics is a biotechnology company that develops allogeneic cellular immunotherapies.
Total Funding Amount:
$3.58M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Seattle, Washington, United States
Founded Date:
2019-01-01
Contact Email:
info(AT)deverratx.com
Founders:
Colleen Delaney
Number of Employees:
11-50
Last Funding Date:
2023-09-11
IPO Status:
Private
Industries:
© 2025 bioDAO.ai